McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a June 13, 2013 edition of Law360.com in an article entitled, “High Court’s Myriad Ruling Won’t Crush Biotech Industry.” The U.S. Supreme Court’s ruling on June 13, 2013 invalidating Myriad Genetics Inc.’s patents on isolated human genes won’t deal a serious financial blow to the biotechnology industry, and could even strengthen it by allowing intellectual property protections for synthetic DNA and giving scientists greater leeway to experiment with genetic material, experts say. View the article